Effectiveness of prescribing similar vs dissimilar devices for COPD management (phase 1)

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/10951
• EU PAS number:
  EUPAS10559
• Study ID:
  10951
• Official title and acronym:
  Effectiveness of prescribing similar vs dissimilar devices for COPD management (phase 1)
• DARWIN EU® study:
  No
• Study countries:
  United Kingdom
• Study description:
  Phase 1 of the study will involve a categorisation (based on required inhalation technique) and descriptive summary of commonly prescribed devices for COPD management.•List of therapies available and inhaler devices prescribed for COPD management in a UK patient population•Categorisation of inhaler devices based on similarities in required inhalation speed and strength for correct use (i.e. groups of similar devices) •Patterns of inhaler device prescriptions, focusing on co-prescriptions for similar and dissimilar devices
• Study status:
  Finalised

Research institution and networks

Institutions

Research in Real Life

Study timelines

Date when funding contract was signed

Actual: 06/02/2015

Study start date

Actual: 11/03/2015

Data analysis start date

Actual: 25/03/2015

Date of interim report, if expected

Actual: 20/05/2015

Date of final study report

Planned: 21/08/2015

Actual: 14/08/2015

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Teva

Study protocol

Initial protocol

DASG study similar vs dissimilar devices COPD_Protocol_phase1

Updated protocol

DASG study similar vs dissimilar devices COPD_Phase 1_Protocol

Regulatory

• Was the study required by a regulatory body?:
  Unknown